Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06931821 · ClinicalTrials.gov registry record · NA
Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial
A NA study, sponsored by University of Arizona.
- Not yet
- Registry status
- NA
- Development phase
- 360
- Enrollment target
NCT06931821 is a NA study that has not yet begun recruiting, run by University of Arizona. The registered enrollment target is 360 participants.
The verdict
NCT06931821, a NA study, has not yet begun recruiting, sponsored by University of Arizona.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
Study Summary
This is a multicenter, prospective, parallel, randomized controlled trial to test for non-inferiority with an ILAM-guided VT ablation compared to conventional voltage- based ablation. The study has two treatment arms: conventional voltage mapping and ablation (control arm). In the investigational arm, the ablation strategy is guided by ILAM to target deceleration zones, blinded to voltage mapping. In the control arm, ablation will be performed to extensively ablate all low voltage regions (\<1.5mV) during sinus rhythm, right ventricular (RV) pacing, or left ventricular (LV) pacing, with discretionary use of pacemapping and activation mapping. In both arms, mapping with be performed with a multielectrode catheter (HD Grid) and ablation will be performed using an irrigated tip catheter (FlexAbility SE or Tactiflex catheters). In the control armonly voltage mapping displays will be utilized (blinded to functional ILAM and fractionation). High density mapping with automated last deflection annotation (Ensite X) will be performed in all patients randomized to ILAM approach during either sinus rhythm or RV pacing.
Interventions
- DEVICE Isochronal Late Activation Mapping (ILAM)
- DEVICE High Density Voltage Mapping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2025-04-15 |
| Est. Completion | 2029-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06931821
The ClinicalTrials.gov registry entry for NCT06931821 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Isochronal Late Activation Mapping (ILAM) is the first listed.
NCT06931821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06931821 about?
NCT06931821 is a clinical study titled "Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial". This is a multicenter, prospective, parallel, randomized controlled trial to test for non-inferiority with an ILAM-guided VT ablation compared to conventional voltage- based ablation. The study has two treatment arms: conventional voltage mapping and ablation (control arm). In the investigational ar...
What is the current status of trial NCT06931821?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2025-04-15. Estimated completion is 2029-04-30.
What interventions are being tested in trial NCT06931821?
The interventions under investigation include: Isochronal Late Activation Mapping (ILAM) (DEVICE), High Density Voltage Mapping (DEVICE).
Who is sponsoring clinical trial NCT06931821?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.